Market Place
Sourcing Support
FDA signs off on generics for AstraZeneca`s Farxiga
13 Apr 2026 //
FDA
U.S. FDA Approves Generic Dapagliflozin for India
09 Apr 2026 //
INDPHARMAPOST
BMJ Finds More Irregularities in Trial Data for Az`s Brilinta
24 Jun 2025 //
FIERCE PHARMA
AstraZeneca approved to sell hyperkalaemia treatment in India
08 Mar 2025 //
ECONOMICTIMES
Sanofi Q1 profit slips on generic competition, forex effects
25 Apr 2024 //
REUTERS
FASENRA met the primary endpoint in the MANDARA Phase III trial in EGPA
11 Sep 2023 //
BUSINESSWIRE
Glenmark gets USFDA nod to market generic diabetes drug
01 Aug 2023 //
ECONOMIC TIMES
Viatris Announces Launch of Breyna™ Inhalation Aerosol
01 Aug 2023 //
PR NEWSWIRE
Glenmark gets USFDA nod to market generic diabetes drug
01 Jul 2023 //
ECONOMIC TIMES
Natco Pharma submits application with USFDA for generic cancer drug
13 Feb 2023 //
ECONOMIC TIMES
In generic drug plants in China and India, data falsification is still a problem
30 Oct 2019 //
STATNEWS
Sandoz-Aurobindo, Zolgensma, AZ and more
25 Oct 2019 //
FIERCE PHARMA
Digital Dose Inhalers Market-Opportunities With AstraZeneca, Novartis,Technavio
20 Sep 2019 //
BUSINESSWIRE
Product Hopping: E&C Hearing Addresses Restrictions to Generic Competition
19 Sep 2019 //
RAPS
Mylan launches generic Faslodex inj in US market to treat advanced breast cancer
19 Sep 2019 //
PHARMABIZ
FDA Approves Generic Fulvestrant Injection for Advanced Breast Cancer
23 Aug 2019 //
PHARMACYTIMES
AstraZeneca`s Faslodex gets U.S. generic on heels of record sales year
31 May 2019 //
FIERCE PHARMA
AZ, BeiGene, Kangmei and more—FiercePharmaAsia
03 May 2019 //
FIERCE PHARMA
Faslodex (Fulvestrant Injection) : Astrazeneca vs. Chia Tai Tianqing Pharma
14 Dec 2018 //
PATENT LITIGATION
Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals
10 Dec 2018 //
PATENT LITIGATION
NEXIUM (esomeprazole magnesium) : Dr. Reddy’s Labs vs. AstraZeneca
24 Nov 2018 //
PATENT LITIGATION
Pomalyst (Pomalidomide): Celgene Corporation vs. Apotex
24 Nov 2018 //
PATENT LITIGATION
Symbicort (budesonide/formoterol fumarate dihydrate) : AstraZeneca vs. Mylan
19 Oct 2018 //
PATENT LITIGATION
Breckenridge Announces Final ANDA Approval of Roflumilast Tablets
06 Oct 2018 //
PR NEWSWIRE
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma
02 Oct 2018 //
PATENT LITIGATION
Linezolid : Symed Labs & Hetero USA v. Amneal Pharmaceuticals
06 Sep 2018 //
PATENT LITIGATION
Faslodex (fulvestrant) : AstraZeneca Pharmaceuticals v. Accord Healthcare
27 Aug 2018 //
PATENT LITIGATION
Brilinta (ticagrelor) : AstraZeneca UK et al v. Hisun Pharmaceutical
18 Aug 2018 //
PATENT LITIGATION
AstraZeneca-DRL patent case: Fate of Rs 2.35 bn drug to be decided today
31 Jul 2018 //
BUSINESS STANDARD
Faslodex¨ (fulvestrant): AstraZeneca v. Accord Healthcare, Inc.
26 Jul 2018 //
PATENT LITIGATION
China answers outcry over cancer drug prices with speedy cuts
10 Jul 2018 //
FIERCE PHARMA
Prescription med: registration of new chemical entities in Australia
09 Jul 2018 //
TGA
Faslodex® (fulvestrant): AstraZeneca Pharmaceuticals LP v. Apotex Corp.
29 Jun 2018 //
PATENT LITIGATION
Farxiga® (Dapagliflozin): Astrazeneca v. Zydus Pharmaceuticals (USA)
03 May 2018 //
PATENT LITIGATION
Amid tough respiratory competition, AZ inks Symbicort outcomes-based deals
19 Apr 2018 //
FIERCE PHARMA
Imbruvica®( Ibrutinib) : Acerta Pharma v. Pharmacyclics
18 Apr 2018 //
PATENT LITIGATION
With Generic and Over-the-Counter Viagra Coming, Pfizer Looks for a Viable
02 Apr 2018 //
BIOSPACE
Faslodex® ( Fulvestrant): Astrazeneca Pharmaceuticals v. Fresenius Kabi Usa
14 Dec 2017 //
PATENT LITIGATION
Korea development: Celltrion prepping to enter US generics market
30 Nov 2017 //
IN PHARMATECHNOLOGIST
US FDA issues guidelines to help generic makers to copy 32 complex drug products
20 Oct 2017 //
MONEY CONTROL
AstraZeneca, Amneal Settle Generic Diabetes Drug Fight
19 Sep 2017 //
LAW360
Generic Seroquel XR tablets launched by Lupin in USA
24 Aug 2017 //
BIOSPECTRUM
Imfinzi (Durvalumab): Bristol-Myers Squib V. Astrazeneca, E. R. Squibb & Sons Ono Tasuku Honjo
26 Jul 2017 //
PATENT LITIGATION
Faslodex (Fulvestrant): AstraZeneca v. HBT Labs
18 Apr 2017 //
PATENT LITIGATION
Faslodex (Fulvestrant): AstraZeneca v. Teva Pharmaceuticals
10 Apr 2017 //
PATENT LITIGATION
Generic version of AZ’s Iressa launched in China
22 Feb 2017 //
PMLIVE
Generic version of top-selling lung cancer drug hits Chinese market
20 Feb 2017 //
PHARMAFILE
FDA`s new citizen petition rules remove speed bumps for generic
10 Nov 2016 //
FIERCE PHARMA
Aralez Completes Acquisition Of Toprol-XL® And Its Authorized Generic
31 Oct 2016 //
PR NEWS WIRE
Intellipharmaceutics Announces FDA tentative approval for generic Seroquel XR®
07 Oct 2016 //
GLOBENEWEWIRE
Indian Firms Get Approval For Generics of AstraZeneca’s Crestor
20 Jul 2016 //
BLOOMBERG
AstraZeneca sues FDA to prevent generic versions of Crestor
29 Jun 2016 //
STAT
AstraZeneca, Teva settle Byetta patent suit; generics on their way
25 Jun 2016 //
FIERCE PHARMA
Generic Crestor market to become crowded in near future
23 May 2016 //
TWO FOUR INSIGHT
Two Indian generics makers end battle to copy drugs amid patent debate
13 Apr 2016 //
REUTERS
Camber Pharma Launches Generic Nexium® Delayed-Release Capsules
24 Sep 2015 //
PR NEWS WIRE
Despite Generic Erosion of Current Market, Asthma Market Will Remain Steady
22 Sep 2015 //
PR NEWS WIRE
Lupin gets USFDA nod for generic ulcer drug
27 Aug 2015 //
THE ECONOMIC TIMES
Diplomat to Dispense AstraZeneca Drug IRESSA®
10 Aug 2015 //
PR NEWS WIRE
Mylan Launches Generic Nexium® Delayed-Release Capsules
06 Aug 2015 //
PR NEWS WIRE
